Status:
RECRUITING
Device Use Reimagined Through Education And Mentorship
Lead Sponsor:
University of California, San Francisco
Collaborating Sponsors:
Children's Hospital Los Angeles
University of California, Davis
Conditions:
Diabetes Mellitus, Type 1
Eligibility:
All Genders
13-17 years
Phase:
NA
Brief Summary
Diabetes technology, such as insulin pumps and continuous glucose monitoring devices, can help improve glucose control for people with type 1 diabetes (T1D), which keeps them at lower risk for diabete...
Detailed Description
This multi-site project has two phases: phase 1 involved stakeholders focus groups to assess barriers and facilitators to diabetes technology and the creation of advisory councils. Feedback was obtain...
Eligibility Criteria
Inclusion
- Adolescents 13-17 years old and their caregivers
- Adolescent must have T1D of any duration, and be receiving diabetes care at UCSF, CHLA or UC Davis
- Self-identify as Latina/o/x or other variations such as Hispanic
- Preferred language of English or Spanish
Exclusion
- Participants who have a medical, developmental, or psychiatric condition that would make peer group participation difficult
- Adolescents who are planning to transfer care to a different medical center within the next year, which would prevent assessment of longitudinal outcomes
Key Trial Info
Start Date :
October 11 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 31 2026
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT06546930
Start Date
October 11 2024
End Date
May 31 2026
Last Update
October 15 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, Davis
Davis, California, United States, 95616
2
Children's Hospital Los Angeles
Los Angeles, California, United States, 90027
3
University of California, San Francisco
San Francisco, California, United States, 94158